Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

PFE 24.44

-1.7%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DavesM who wrote (1557)	5/17/1999 5:38:00 AM
From: Anthony Wong	of 1722

Pfizer, Bristol-Myers Among Kolbert's Top Picks, Barron's Says Bloomberg News May 16, 1999, 6:38 p.m. ET New York, May 16 (Bloomberg) -- Pfizer Inc., Bristol-Myers Squibb Co., Eli Lilly and Co. and Merck & Co. are among the drug stocks favored by Salomon Smith Barney Inc.'s David Kolbert, Barron's says. Kolbert, who said drug shares are undervalued and represent a buying opportunity, said the industry's fundamentals remain strong as advancements in the field of biotechnology and a graying U.S. population spur sales. Companies such as Viagra maker Pfizer Inc. and Propecia maker Merck have been advertising directly to consumers, encouraging them to ask physicians for the drugs directly, Kolbert told Barron's. New York-based Pfizer was sued earlier this month for more than $100 million by two companies seeking to bar the fourth- largest drugmaker from using the name Trovan to market a popular antibiotic. (Barron's 5/17 H19 www.barrons.com)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next